Navigation Links
Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
Date:10/1/2008

ces, Inc.

Headquartered in Newnan, near Atlanta, Georgia, CeloNova BioSciences, Inc., is a developer of novel medical devices that are then enhanced by one of the Company's proprietary materials, Polyzene(R)-F. Polyzene(R)-F is highly lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant making it an ideal surface treatment for implanted medical devices. The Company's current products include its Embozene(TM) Color-Advanced Microspheres and the CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F. Other innovative devices are currently in the company's developmental pipeline. For more information, please visit http://www.celonova.com .

CONTACT: Robert J. Murphy

The Storch-Murphy Group

908-276-0777


'/>"/>
SOURCE CeloNova BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
2. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
3. Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference
4. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
5. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
8. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
9. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
10. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
11. Hot Information for Physicians Treating Vasomotor Symptoms During the Menopausal Transition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Fla., Dec. 14 Dyadic International, Inc. ... has extended its collaboration with The Scripps Research ... Scripps to re-annotate the genome of Dyadic,s patented ... is a continuation of the successful relationship between ... when Dyadic engaged Scripps to annotate the C1 ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
(Date:12/14/2009)... Mass., Dec. 14 Lionbridge (Nasdaq: ... has signed a new, three-year master services ... with products and services that serve patients ... Lionbridge will become the sole provider for ... includes regulatory, marketing, training, human resources, legal, ...
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... the atrial fibrillation drug market will increase more ... $6.1 billion in 2018 in the United States, ... Japan. ,, The new Pharmacor report entitled ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... Instrument, a world-leading flow measurement and control provider, ... controller, a totally new family of mass flow ... pressure and temperature. Built on a standard 1.125-inch ... local digital display, the B-Series provides a compact ...
... for rural Indians - Leverages Satyam,s earlier success with ... (NYSE: SAY ) a leading global consulting ... was honored, along with the LV Prasad Eye Institute, ... program, which provides expert and affordable eye care to ...
... Inc. (NYSE Alternext US: DDD) today reported financial results ... 2008. The Company will host a live conference ... Daylight Time)."Last year was an important period for SCOLR ... M.B.A. "Utilizing our unique CDT(R) platforms, we made significant ...
Other Biology Technology:Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations 2Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Fluctuations 3Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 2Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 3Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 4SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 7SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 8
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
(Date:12/14/2009)... Springer and the Biomedical Engineering Society (BMES) have founded ... ( CVET ). CVET is a ... and medical treatment. The first issue of the ... joins two other BMES publications at Springer, Annals ... Bioengineering . , Cardiovascular Engineering and Technology ...
(Date:12/14/2009)... United Nations Framework Convention on Climate Change taking ... the ,Bend the Trend, event on Sunday evening ... premiere the screening of the new ,Environmental Atlas ... a joint project of the European Environment Agency ... is a series of short films showing the ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2'Environmental Atlas of Europe' unveiled at COP15 2National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of Notes on Nursing e book 60784 1National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of Notes on Nursing e book 60784 2OncoGenex Reports Third Quarter 2009 Financial Results 14740 1OncoGenex Reports Third Quarter 2009 Financial Results 14740 2OncoGenex Reports Third Quarter 2009 Financial Results 14740 3OncoGenex Reports Third Quarter 2009 Financial Results 14740 4OncoGenex Reports Third Quarter 2009 Financial Results 14740 5OncoGenex Reports Third Quarter 2009 Financial Results 14740 6OncoGenex Reports Third Quarter 2009 Financial Results 14740 7OncoGenex Reports Third Quarter 2009 Financial Results 14740 8ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2
... VeCommerce, a speech self-service,company based in Acton, MA, ... Community Bankers a unique lesson in how to ... "VeCommerce Voice Biometric $1000 Challenge," VeCommerce,offered a $1000 ... VeVerify,the VeCommerce voice biometrics application. With appropriate multifactor,authentication ...
... colonies on islands are highly vulnerable to introduced rats, which ... ecological impacts of rats on islands extend far beyond seabird ... the University of California, Santa Cruz. , The study, ... in the Proceedings of the National Academy of Sciences, has ...
... Scripps Institution of Oceanography at UC San Diego to ... Ocean has yielded an unprecedented wealth of information about ... exploration of four atolls in the Line Islands, part ... Hawaii, has produced the first study of coral reefs ...
Other Biology News:VeCommerce's Voice Biometrics Wins Challenge 2Rats on islands disrupt ecosystems from land to sea, researchers find 2Rats on islands disrupt ecosystems from land to sea, researchers find 3Scripps expedition provides new baseline for coral reef conservation 2Scripps expedition provides new baseline for coral reef conservation 3
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
...
... system uses the Adept CE 4100 high pressure ... dual wavelength detector for added flexibility. ... processing software and interface unit, CE 4901., The ... may also be used with Windows 98 and ...
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
Biology Products: